BFM
CNMD icon

Boothbay Fund Management’s CONMED CNMD Stock Holding History

Boothbay Fund Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,573
Closed -$798K – 2297
2026
Q1 		$798K Buy
22,573
+8,391
+59% +$341K 0.01% 1071
2025
Q4 		$576K Buy
14,182
+6,796
+92% +$296K 0.01% 1056
2025
Q3 		$347K Buy
+7,386
New +$383K 0.01% 1366
2024
Q2 		– Sell
-93,014
Closed -$7.45M – 1569
2024
Q1 		$7.45M Buy
+93,014
New +$8.29M 0.14% 120
2023
Q1 		– Sell
-37,998
Closed -$3.37M – 2178
2022
Q4 		$3.37M Buy
37,998
+20,911
+122% +$1.74M 0.08% 372
2022
Q3 		$1.37M Buy
+17,087
New +$1.61M 0.03% 737

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Boothbay Fund Management's CNMD Position: Q2 2026 in Review

Boothbay Fund Management sold out of CONMED (CNMD) in Q2 2026, closing a stake of 22,573 shares — an estimated $798K sold.

Boothbay Fund Management first reported a position in CNMD in Q3 2022 and held it in 6 quarters. The position peaked at $7.45M in Q1 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Boothbay Fund Management reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 22,573 CONMED shares in Q2 2026, an estimated $798K.
  • Boothbay Fund Management first reported a position in CONMED in Q3 2022 and held it in 6 quarters.
  • Boothbay Fund Management's CONMED position peaked at $7.45M in Q1 2024.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.